Skip to main content
ARROWHEAD PHARMACEUTICALS, INC. logo

ARROWHEAD PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · ARWR ISIN · US04280A1007 LEI · 549300O3CSB8T7OZ3D66 US Manufacturing
Open in API
Filings indexed 1,039 across all filing types
Latest filing 2010-12-22 Regulatory Filings
Country US United States of America
Listing US ARWR

About ARROWHEAD PHARMACEUTICALS, INC.

https://arrowheadpharma.com/

Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated December 22, 2010. It announces the company's fourth quarter and year-end financial results for the period ended September 30, 2010, and includes a press release as an exhibit. The text explicitly states that the information is furnished and not filed, and it references a press release rather than containing detailed financial statements or substantive financial data itself. The document length is 2772 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document that announces or furnishes financial results without containing the full report or detailed financial data should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2010-12-22 English
FORM 10-K
Annual Report FY 2010
2010-12-22 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated December 14, 2010. It announces the entry into a material definitive agreement regarding an exclusive license for anti-obesity technology. The content is a brief summary of the agreement terms and does not contain financial statements or detailed financial analysis. The document is short (2558 characters) and serves as a regulatory announcement of a material event rather than a full financial report or detailed management discussion. Therefore, it fits the category of a Regulatory Filing (RNS), which is the fallback for miscellaneous SEC filings that do not fit other specific categories.
2010-12-20 English
FORM 8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically discusses a notice of deficiency from NASDAQ regarding the company's failure to meet the minimum bid price requirement and the potential delisting consequences. This matches the description of a Delisting Announcement. The document is relatively short (2983 characters) and contains detailed information about the delisting issue, not just a notice of report publication or certification. Therefore, the appropriate classification is DLST (Delisting Announcement).
2010-12-14 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into material definitive agreements related to intellectual property and licensing with Samsung Electronics. It summarizes the agreements and mentions that full details will be filed with the upcoming quarterly report (Form 10-Q). The document is not a full financial report, earnings release, or management discussion, but rather an announcement of a significant corporate event. Therefore, it fits the category of a Regulatory Filing (RNS), which is the fallback for miscellaneous filings that do not fit other specific categories. The document length is 4037 characters, which is relatively short and consistent with an 8-K current report announcement rather than a full report.
2010-12-09 English
STOCK OPTION GRANT - JUNE 2010
Director's Dealing
2010-12-08 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.